Sitafloxacin

WikiDoc Resources for Sitafloxacin
Articles
Most recent articles on Sitafloxacin Most cited articles on Sitafloxacin Review articles on Sitafloxacin Articles on Sitafloxacin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Sitafloxacin Images of Sitafloxacin Photos of Sitafloxacin Podcasts & MP3s on Sitafloxacin Videos on Sitafloxacin
Evidence Based Medicine
Cochrane Collaboration on Sitafloxacin Bandolier on Sitafloxacin TRIP on Sitafloxacin
Clinical Trials
Ongoing Trials on Sitafloxacin at Clinical Trials.gov Trial results on Sitafloxacin Clinical Trials on Sitafloxacin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Sitafloxacin NICE Guidance on Sitafloxacin NHS PRODIGY Guidance FDA on Sitafloxacin CDC on Sitafloxacin
Books
Books on Sitafloxacin
News
Sitafloxacin in the news Be alerted to news on Sitafloxacin News trends on Sitafloxacin
Commentary
Blogs on Sitafloxacin
Definitions
Definitions of Sitafloxacin
Patient Resources / Community
Patient resources on Sitafloxacin Discussion groups on Sitafloxacin Patient Handouts on Sitafloxacin Directions to Hospitals Treating Sitafloxacin Risk calculators and risk factors for Sitafloxacin
Healthcare Provider Resources
Symptoms of Sitafloxacin Causes & Risk Factors for Sitafloxacin Diagnostic studies for Sitafloxacin Treatment of Sitafloxacin
Continuing Medical Education (CME)
CME Programs on Sitafloxacin
International
Sitafloxacin en Espanol Sitafloxacin en Francais
Business
Sitafloxacin in the Marketplace Patents on Sitafloxacin
Experimental / Informatics
List of terms related to Sitafloxacin

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Sitafloxacin (also called DU-6859a) is a fluoroquinolone antibiotic that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Pharmaceutical Co. Ltd, who have also brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently under development in Japan.